Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study
Titel:
Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study
Auteur:
Garcia-Manero, Guillermo Goldberg, Aaron D Winer, Eric S Altman, Jessica K Fathi, Amir T Odenike, Olatoyosi Roboz, Gail J Sweet, Kendra Miller, Crystal Wennborg, Anders Hickman, Denice K Kanagal-Shamanna, Rashmi Kantarjian, Hagop Lancet, Jeffrey Komrokji, Rami Attar, Eyal C Sallman, David A